Improvement in survival and quality of life with new therapeutic agents in metastatic castration-resistant prostate cancer: comparison among the results.

Recine, F; Ceresoli, G L; Baciarello, G; Cerbone, L; Calabrò, F

Recine, F; Ceresoli, G L; Baciarello, G; Cerbone, L; Calabrò, F.

Affiliation

Recine F; Department of Oncology, San Camillo Forlanini Hospital, Rome, Italy - giovanni_luca.ceresoli@gavazzeni.it.

Q J Nucl Med Mol Imaging ; 59(4): 400-10, 2015 Dec.

Article in En | MEDLINE | ID: mdl-26337241

Subject(s)

Antineoplastic Agents/pharmacology; Prostatic Neoplasms, Castration-Resistant/drug therapy; Prostatic Neoplasms, Castration-Resistant/pathology; Quality of Life; Animals; Antineoplastic Agents/therapeutic use; Humans; Immunotherapy; Male; Neoplasm Metastasis; Prostatic Neoplasms, Castration-Resistant/immunology; Prostatic Neoplasms, Castration-Resistant/radiotherapy; Survival Analysis

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Prostatic Neoplasms, Castration-Resistant / Antineoplastic Agents Aspects: Patient_preference Limits: Animals / Humans / Male Language: En Journal: Q J Nucl Med Mol Imaging Year: 2015 Document type: Article

Search on Google

XML

PubMed Links